Nuformix Plc (LSE: NFX)
GBX 0.10
(0.0%)
GBX 0.00
Price as of June 20, 2025, 4:07 a.m. ET
Nuformix Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nuformix Plc Company Info
Nuformix Plc is a pharmaceutical development company, which targets unmet medical needs in fibrosis and oncology via drug repurposing. It focuses on cocrystal technology. Its products include NXP001, NXP002, and NXP004. The company was founded by Joanne Holland, Daniel Gooding, and David Tapolczay in 2008 and is headquartered in London, the United Kingdom.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.